Here are five notes:
1. Mr. Minogue will help Bioventus expand its global growth in orthobiologics.
2. Mr. Minogue is the CEO, president and chairman of Danvers, Mass.-based Abiomed.
3. He also serves as chairman of Medical Device Industry Consortium and on the executive board of directors for AdvaMed.
4. Mr. Minogue earned his master’s of business administration degree from University of Chicago.
5. He replaces Evan Melrose, MD, MBA, on the board.
More articles on devices:
Zimmer Biomet celebrates 40 years of Oxford Partial Knee System use: 4 key takeaways
OrthoPediatrics releases PediLoc Infant LPF Plating System: 4 things to know
Global sports medicine devices market to reach $8.63B by 2020: 3 highlights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
